UK drugmaker in China bribery probe

GlaxoSmithKline's British and Chinese executives accused of paying off health institutions to use their pricey products.

    Police in China have completed an investigation into a suspected bribery case involving the multinational pharmaceutical company GlaxoSmithKline (GSK) and handed it over to prosecutors on Wednesday.

    After an almost year-long investigation, police alleged that William Mark Reilly, a British national and executive of GSK China, and two Chinese executives, Zhang Guowei and Zhao Hongyan, bribed Chinese hospitals, doctors and health institutions, to use their products.

    The drugmaker GSK China used illegal means to maximise profit, its former employees alleged.

    Al Jazeera's Tim Friend reports from London.

    SOURCE: Al Jazeera


    YOU MIGHT ALSO LIKE

    Interactive: Coding like a girl

    Interactive: Coding like a girl

    What obstacles do young women in technology have to overcome to achieve their dreams? Play this retro game to find out.

    Heron Gate mass eviction: 'We never expected this in Canada'

    Hundreds face mass eviction in Canada's capital

    About 150 homes in one of Ottawa's most diverse and affordable communities are expected to be torn down in coming months

    I remember the day … I designed the Nigerian flag

    I remember the day … I designed the Nigerian flag

    In 1959, a year before Nigeria's independence, a 23-year-old student helped colour the country's identity.